Pregnancies complicated by multidrug-resistant tuberculosis and HIV co-infection in Durban, South Africa
- PMID: 17519106
Pregnancies complicated by multidrug-resistant tuberculosis and HIV co-infection in Durban, South Africa
Abstract
Setting: Tertiary hospitals in KwaZulu Natal, South Africa.
Objective: To study the impact of multidrug-resistant tuberculosis (MDR-TB) and human immunodeficiency virus-1 (HIV-1) co-infection during pregnancy on maternal and perinatal outcome.
Design: Prospective study performed between 1996 and 2001. Symptomatic pregnant women were investigated for TB. Those with confirmed MDR-TB were reported on.
Results: Three of five pregnant women with MDR-TB were HIV-1 co-infected. One woman decided to terminate the pregnancy and one experienced pre-term labour. Two neonates had features of growth restriction.
Conclusion: Management of pregnant women with MDR-TB in an HIV-endemic area is possible in developing countries.
Similar articles
-
Vertical transmission of Mycobacterium tuberculosis in KwaZulu Natal: impact of HIV-1 co-infection.Int J Tuberc Lung Dis. 2004 Jan;8(1):59-69. Int J Tuberc Lung Dis. 2004. PMID: 14974747
-
Nosocomial transmission of the F15/LAM4/KZN genotype of Mycobacterium tuberculosis in patients on tuberculosis treatment.Int J Tuberc Lung Dis. 2010 Feb;14(2):223-30. Int J Tuberc Lung Dis. 2010. PMID: 20074415
-
Multidrug-resistant tuberculous meningitis in children in Durban, South Africa.Pediatr Infect Dis J. 2006 Feb;25(2):147-50. doi: 10.1097/01.inf.0000199314.88063.4c. Pediatr Infect Dis J. 2006. PMID: 16462292
-
Current issues in maternal and perinatal tuberculosis: impact of the HIV-1 epidemic.Semin Neonatol. 2000 Aug;5(3):189-96. doi: 10.1053/siny.2000.0022. Semin Neonatol. 2000. PMID: 10956444 Review.
-
Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.J Infect Dis. 2007 Dec 1;196 Suppl 3:S482-90. doi: 10.1086/521121. J Infect Dis. 2007. PMID: 18181698 Review.
Cited by
-
Tuberculosis care for pregnant women: a systematic review.BMC Infect Dis. 2014 Nov 19;14:617. doi: 10.1186/s12879-014-0617-x. BMC Infect Dis. 2014. PMID: 25407883 Free PMC article.
-
Clinical Pharmacokinetics and Pharmacodynamics of Anti-Tubercular Drugs in Pregnancy.Eur J Drug Metab Pharmacokinet. 2021 Jan;46(1):1-24. doi: 10.1007/s13318-020-00657-x. Eur J Drug Metab Pharmacokinet. 2021. PMID: 33206364 Review.
-
Healthcare Provider Discrimination toward Pregnant Women with Rifampin-Resistant Tuberculosis.Emerg Infect Dis. 2019 Mar;25(3):609-610. doi: 10.3201/eid2503.181571. Emerg Infect Dis. 2019. PMID: 30789334 Free PMC article.
-
"Take the treatment and be brave": Care experiences of pregnant women with rifampicin-resistant tuberculosis.PLoS One. 2020 Dec 21;15(12):e0242604. doi: 10.1371/journal.pone.0242604. eCollection 2020. PLoS One. 2020. PMID: 33347448 Free PMC article.
-
Multidrug-Resistant Tuberculosis during Pregnancy: Two Case Reports and Review of the Literature.Case Rep Obstet Gynecol. 2016;2016:1536281. doi: 10.1155/2016/1536281. Epub 2016 Feb 24. Case Rep Obstet Gynecol. 2016. PMID: 27006843 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
